folic acid has been researched along with rhodamine 6g in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Jesús, MA; Giesfeldt, KS; Sepaniak, MJ | 1 |
| Huang, X; Jeong, YI; Kang, DH; Kim, I; Moon, BK; Zhang, L | 1 |
| Baigude, H; Gao, X; Hai, X; Li, Z; Shen, B; Su, H; Tan, Z; Yu, S; Zhang, R | 1 |
| Jia, X; Liu, L; Liu, P; Tian, K; Zeng, J; Zhao, X; Zhou, T | 1 |
4 other study(ies) available for folic acid and rhodamine 6g
| Article | Year |
|---|---|
Use of a sample translation technique to minimize adverse effects of laser irradiation in surface-enhanced Raman spectrometry.
Topics: Aniline Compounds; Artifacts; Equipment Failure; Equipment Failure Analysis; Folic Acid; Lasers; Naproxen; Quality Control; Radiation Dosage; Reproducibility of Results; Rhodamines; Riboflavin; Rotation; Scattering, Radiation; Sensitivity and Specificity; Specimen Handling; Spectrum Analysis, Raman; Sulfhydryl Compounds | 2003 |
Self-assembly of morphology-tunable architectures from tetraarylmethane derivatives for targeted drug delivery.
Topics: Cell Line; Cell Line, Tumor; Doxorubicin; Drug Carriers; Folic Acid; Humans; Magnetic Resonance Spectroscopy; Molecular Docking Simulation; Nanospheres; Rhodamines | 2013 |
Inorganic nanovehicle for potential targeted drug delivery to tumor cells, tumor optical imaging.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Chitosan; Drug Carriers; Ferrosoferric Oxide; Fluorouracil; Folic Acid; HEK293 Cells; HeLa Cells; Humans; Magnetite Nanoparticles; Microscopy, Confocal; Nanostructures; Rhodamines; Zirconium | 2015 |
Double-Cross-Linked Hyaluronic Acid Nanoparticles with pH/Reduction Dual-Responsive Triggered Release and pH-Modulated Fluorescence for Folate-Receptor-Mediated Targeting Visualized Chemotherapy.
Topics: Antineoplastic Agents; Cell Line, Tumor; Delayed-Action Preparations; Doxorubicin; Drug Carriers; Drug Liberation; Folic Acid; HeLa Cells; Humans; Hyaluronan Receptors; Hyaluronic Acid; Nanoparticles; Neoplasms; Rhodamines | 2016 |